CAS RN: 255829-30-2
4-(3,6-Di-tert-butyl-9H-carbazol-9-yl)aniline
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250628 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260326 |
1g |
In stock |
Shanghai | | Inquiry |
| Batchno.20260607 |
1g |
Out of stock |
| 5-7 business days | Inquiry |
| Batchno.20250428 |
200mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250629 |
250mg |
In stock |
Shanghai | | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: >98%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 255829-30-2
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>98% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>98% |
5
In Stock
|
Shanghai |
Inquiry |
| 1g |
>98% |
5
In Stock
|
Hong Kong |
Inquiry |
255829-30-2 / 4-(3,6-ditert-butylcarbazol-9-yl)aniline
Standard CAS: 255829-30-2
Multi CAS: No
Basic Information
CAS
255829-30-2
Multi CAS
No
Molecular Formula
C26H30N2
Molecular Weight
370.500000
Exact Mass
370.240899
SMILES
CC(C)(C)C1=CC2=C(C=C1)N(C3=C2C=C(C=C3)C(C)(C)C)C4=CC=C(C=C4)N
InChI
InChI=1S/C26H30N2/c1-25(2,3)17-7-13-23-21(15-17)22-16-18(26(4,5)6)8-14-24(22)28(23)20-11-9-19(27)10-12-20/h7-16H,27H2,1-6H3
InChIKey
GBVGWEMDOXNWOP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
28
Aromatic heavy atom count
19
Fraction Csp3
0.31
Rotatable bonds
1
H-bond acceptors
2
H-bond donors
1
Molar refractivity
122.59
TPSA
30.95
LogP / Solubility
WLOGP
6.96
MLOGP
6.15
XLogP3
7.7
Consensus LogP
6.94
Log S (ESOL)
-6.96
Class (ESOL)
Insoluble
Log S (Ali)
-7.62
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.97
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.04
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.55
PAINS alerts
1
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3